Obesity and gastrointestinal cancers: Epidemiology

Energy Balance and Gastrointestinal Cancer

Volumn , Issue , 2012, Pages 1-22

  Nock, Nora L ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84870188866     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4614-2367-6_1     Document Type: Chapter

References (96)

1. World Health Organization (2000) Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organization, Geneva
2. Kershaw EE, Flier JS (2004) Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 89:2548-2556
3. Rankinen T, Kim SY, Perusse L, Despres JP, Bouchard C (1999) The prediction of abdominal visceral fat level from body composition and anthropometry: ROC analysis. Int J Obes Relat Metab Disord 23:801-809
4. Smith SR, Lovejoy JC, Greenway F, Ryan D, deJonge L, de la Bretonne J, Volafova J, Bray GA (2001) Contributions of total body fat, abdominal subcutaneous adipose tissue compartments, and visceral adipose tissue to the metabolic complications of obesity. Metabolism 50:425-435
5. Despres JP (2006) Is visceral obesity the cause of the metabolic syndrome? Ann Med 38:52-63
6. Despres JP, Lemieux I (2006) Abdominal obesity and metabolic syndrome. Nature 444:881-887
7. Pothiwala P, Jain SK, Yaturu S (2009) Metabolic syndrome and cancer. Metab Syndr Relat Disord 7:279-288
8. van Kruijsdijk RC, van der Wall E, Visseren FL (2009) Obesity and cancer: the role of dysfunctional adipose tissue. Cancer Epidemiol Biomarkers Prev 18:2569-2578
9. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC Jr (2009) Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120:1640-1645
10. Hara K, Matsushita Y, Horikoshi M, Yoshiike N, Yokoyama T, Tanaka H, Kadowaki T (2006) A proposal for the cutoff point of waist circumference for the diagnosis of metabolic syndrome in the Japanese population. Diabetes Care 29:1123-1124
11. Goodpaster BH (2002) Measuring body fat distribution and content in humans. Curr Opin Clin Nutr Metab Care 5:481-487
12. Pietrobelli A, Boner AL, Tato L (2005) Adipose tissue and metabolic effects: new insight into measurements. Int J Obes (Lond) 29(suppl 2):S97-S100
13. Caterson ID, Gill TP (2002) Obesity: epidemiology and possible prevention. Best Pract Res Clin Endocrinol Metab 16:595-610
14. Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM (2008) Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 295:1549-1555
15. World Health Organization (2003) World cancer report. IARC Nonserial Publication, Geneva, Switzerland
16. Finucane MM, Stevens GA, Cowan MJ, Danaei G, Lin JK, Paciorek CJ, Singh GM, Gutierrez HR, Lu Y, Bahalim AN, Farzadfar F, Riley LM, Ezzati M (2011) National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9.1 million participants. Lancet 377:557-567
17. Ogden CL, Yanvoski SZ, Carroll MD, Flegal KM (2007) The epidemiology of obesity. Gastroenterology 132:2087-2102
18. Flegal KM, Carroll MD, Ogden CL, Curtin LR (2010) Prevalence and trends in obesity among US adults, 1999-2008. JAMA 303:235-241
19. Zaninotto P, Wardle H, Stamatakis E, Mindell J, Head J (2006) Forecasting obesity to 2010. National Centre for Social Research/Department of Health, London
20. Berghofer A, Pischon T, Reinhold T, Apovian CM, Sharma AM, Willich SN (2008) Obesity prevalence from a European perspective: a systematic review. BMC Public Health 8:200
21. Orsi CM, Hale DE, Lynch JL (2011) Pediatric obesity epidemiology. Curr Opin Endocrinol Diabetes Obes 18:14-22
22. The NS, Suchindran C, North KE, Popkin BM, Gordon-Larsen P (2010) Association of adolescent obesity with risk of severe obesity in adulthood. JAMA 304:2042-2047
23. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61:69-90
24. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127:2893-2917
25. Siegel R, Ward E, Brawley O, Jemal A (2011) Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 61:212-236
26. Enzinger PC, Mayer RJ (2003) Esophageal cancer. N Engl J Med 349:2241-2252
27. Corley DA (2007) Obesity and the rising incidence of oesophageal and gastric adenocarcinoma: what is the link? Gut 56:1493-1494
28. Pera M, Manterola C, Vidal O, Grande L (2005) Epidemiology of esophageal adenocarcinoma. J Surg Oncol 92:151-159
29. Wayman J, Forman D, Griffin SM (2001) Monitoring the changing pattern of esophago-gastric cancer: data from a UK regional cancer registry. Cancer Causes Control 12:943-949
30. Howe HL, Wu X, Ries LA, Cokkinides V, Ahmed F, Jemal A, Miller B, Williams M, Ward E, Wingo PA, Ramirez A, Edwards BK (2006) Annual report to the nation on the status of cancer, 1975-2003, featuring cancer among U.S. Hispanic/Latino populations. Cancer 107:1711-1742
31. World Health Organization (2008) The Global Burden of Disease: 2004 Update. World Health Organization, Geneva
32. Malvezzi M, Arfe A, Bertuccio P, Levi F, La VC, Negri E (2011) European cancer mortality predictions for the year 2011. Ann Oncol 22:947-956
33. Karim-Kos HE, Kiemeney LA, Louwman MW, Coebergh JW, Vries ED (2011) Progress against cancer in the Netherlands since the late 1980s: an epidemiological evaluation. Int J Cancer 2011 Jul 25. doi: 10.1002/ijc.26315
34. Alberti KG, Zimmet PZ (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15:539-553
35. Balkau B, Charles MA (1999) Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR). Diabet Med 16:442-443
36. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (2001) Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285:2486-2497
37. Alberti KG, Zimmet P, Shaw J (2005) The metabolic syndrome-a new worldwide definition. Lancet 366:1059-1062
38. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC Jr, Spertus JA, Costa F (2006) Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Curr Opin Cardiol 21:1-6
39. Halpern A, Mancini MC, Magalhaes ME, Fisberg M, Radominski R, Bertolami MC, Bertolami A, de Melo ME, Zanella MT, Queiroz MS, Nery M (2010) Metabolic syndrome, dyslipidemia, hypertension and type 2 diabetes in youth: from diagnosis to treatment. Diabetol Metab Syndr 2:55
40. Ford ES, Giles WH, Dietz WH (2002) Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 287:356-359
41. Cook S, Auinger P, Li C, Ford ES (2008) Metabolic syndrome rates in United States adolescents, from the National Health and Nutrition Examination Survey, 1999-2002. J Pediatr 152:165-170
42. Athyros VG, Mikhailidis DP, Papageorgiou AA, Didangelos TP, Ganotakis ES, Symeonidis AN, Daskalopoulou SS, Kakafika AI, Elisaf M (2004) Prevalence of atherosclerotic vascular disease among subjects with the metabolic syndrome with or without diabetes mellitus: the METS-GREECE Multicentre Study. Curr Med Res Opin 20:1691-1701
43. Dai Z, Xu YC, Niu L (2007) Obesity and colorectal cancer risk: a meta-analysis of cohort studies. World J Gastroenterol 13:4199-4206
44. Larsson SC, Wolk A (2007) Obesity and colon and rectal cancer risk: a meta-analysis of prospective studies. Am J Clin Nutr 86:556-565
45. Moghaddam AA, Woodward M, Huxley R (2007) Obesity and risk of colorectal cancer: a metaanalysis of 31 studies with 70, 000 events. Cancer Epidemiol Biomarkers Prev 16:2533-2547
46. Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M (2008) Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 371:569-578
47. Harriss DJ, Atkinson G, George K, Cable NT, Reilly T, Haboubi N, Zwahlen M, Egger M, Renehan AG (2009) Lifestyle factors and colorectal cancer risk (1): systematic review and meta-analysis of associations with body mass index. Colorectal Dis 11:547-563
48. Kubo A, Corley DA (2006) Body mass index and adenocarcinomas of the esophagus or gastric cardia: a systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev 15:872-878
49. Larsson SC, Wolk A (2007) Obesity and the risk of gallbladder cancer: a meta-analysis. Br J Cancer 96:1457-1461
50. Yang P, Zhou Y, Chen B, Wan HW, Jia GQ, Bai HL, Wu XT (2009) Overweight, obesity and gastric cancer risk: results from a meta-analysis of cohort studies. Eur J Cancer 45:2867-2873
51. Larsson SC, Wolk A (2007) Overweight, obesity and risk of liver cancer: a meta-analysis of cohort studies. Br J Cancer 97:1005-1008
52. Berrington de GA, Sweetland S, Spencer E (2003) A meta-analysis of obesity and the risk of pancreatic cancer. Br J Cancer 89:519-523
53. Larsson SC, Orsini N, Wolk A (2007) Body mass index and pancreatic cancer risk: A metaanalysis of prospective studies. Int J Cancer 120:1993-1998
54. Donohoe CL, Pidgeon GP, Lysaght J, Reynolds JV (2010) Obesity and gastrointestinal cancer. Br J Surg 97:628-642
55. Frezza EE, Wachtel MS, Chiriva-Internati M (2006) Influence of obesity on the risk of developing colon cancer. Gut 55:285-291
56. Renehan AG, Soerjomataram I, Leitzmann MF (2010) Interpreting the epidemiological evidence linking obesity and cancer: a framework for population-attributable risk estimations in Europe. Eur J Cancer 46:2581-2592
57. Nock NL, Thompson CL, Tucker TC, Berger NA, Li L (2008) Associations between obesity and changes in adult BMI over time and colon cancer risk. Obesity (Silver Spring) 16:1099-1104
58. Moore LL, Bradlee ML, Singer MR, Splansky GL, Proctor MH, Ellison RC, Kreger BE (2004) BMI and waist circumference as predictors of lifetime colon cancer risk in Framingham Study adults. Int J Obes Relat Metab Disord 28:559-567
59. Jacobs ET, Ahnen DJ, Ashbeck EL, Baron JA, Greenberg ER, Lance P, Lieberman DA, McKeown-Eyssen G, Schatzkin A, Thompson PA, Martinez ME (2009) Association between body mass index and colorectal neoplasia at follow-up colonoscopy: a pooling study. Am J Epidemiol 169:657-666
60. Sedjo RL, Byers T, Levin TR, Haffner SM, Saad MF, Tooze JA, D'Agostino RB Jr (2007) Change in body size and the risk of colorectal adenomas. Cancer Epidemiol Biomarkers Prev 16:526-531
61. Morois S, Mesrine S, Josset M, Clavel-Chapelon F, Boutron-Ruault MC (2010) Anthropometric factors in adulthood and risk of colorectal adenomas: the French E3N-EPIC prospective cohort. Am J Epidemiol 172:1166-1180
62. Heo M, Allison DB, Fontaine KR (2004) Overweight, obesity, and colorectal cancer screening: disparity between men and women. BMC Public Health 4:53
63. Anand G, Katz PO (2008) Gastroesophageal reflux disease and obesity. Rev Gastroenterol Disord 8:233-239
64. Lin SW, Freedman ND, Hollenbeck AR, Schatzkin A, Abnet CC (2011) Prospective study of self-reported diabetes and risk of upper gastrointestinal cancers. Cancer Epidemiol Biomarkers Prev 20:954-961
65. Kamat P, Wen S, Morris J, Anandasabapathy S (2009) Exploring the association between elevated body mass index and Barrett's esophagus: a systematic review and meta-analysis. Ann Thorac Surg 87:655-662
66. Stinton LM, Myers RP, Shaffer EA (2010) Epidemiology of gallstones. Gastroenterol Clin North Am 39:157-169, vii
67. Rustagi T, Dasanu CA (2011) Risk factors for gallbladder cancer and cholangiocarcinoma: similarities, differences and updates. J Gastrointest Cancer 2011 May 20
68. Angulo P (2007) Obesity and nonalcoholic fatty liver disease. Nutr Rev 65:S57-S63
69. Carrion AF, Ghanta R, Carrasquillo O, Martin P (2011) Chronic liver disease in the Hispanic population of the United States. Clin Gastroenterol Hepatol 9(10):834-841
70. Neuschwander-Tetri BA, Caldwell SH (2003) Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference. Hepatology 37:1202-1219
71. Jiao L, de Berrington GA, Hartge P, Pfeiffer RM, Park Y, Freedman DM, Gail MH, Alavanja MC, Albanes D, Beane Freeman LE, Chow WH, Huang WY, Hayes RB, Hoppin JA, Ji BT, Leitzmann MF, Linet MS, Meinhold CL, Schairer C, Schatzkin A, Virtamo J, Weinstein SJ, Zheng W, Stolzenberg-Solomon RZ (2010) Body mass index, effect modifiers, and risk of pancreatic cancer: a pooled study of seven prospective cohorts. Cancer Causes Control 21:1305-1314
72. Arslan AA, Helzlsouer KJ, Kooperberg C, Shu XO, Steplowski E, Bueno-de-Mesquita HB, Fuchs CS, Gross MD, Jacobs EJ, Lacroix AZ, Petersen GM, Stolzenberg-Solomon RZ, Zheng W, Albanes D, Amundadottir L, Bamlet WR, Barricarte A, Bingham SA, Boeing H, Boutron- Ruault MC, Buring JE, Chanock SJ, Clipp S, Gaziano JM, Giovannucci EL, Hankinson SE, Hartge P, Hoover RN, Hunter DJ, Hutchinson A, Jacobs KB, Kraft P, Lynch SM, Manjer J, Manson JE, McTiernan A, McWilliams RR, Mendelsohn JB, Michaud DS, Palli D, Rohan TE, Slimani N, Thomas G, Tjonneland A, Tobias GS, Trichopoulos D, Virtamo J, Wolpin BM, Yu K, Zeleniuch-Jacquotte A, Patel AV (2010) Anthropometric measures, body mass index, and pancreatic cancer: a pooled analysis from the Pancreatic Cancer Cohort Consortium (PanScan). Arch Intern Med 170:791-802
73. Gumbs AA (2008) Obesity, pancreatitis, and pancreatic cancer. Obes Surg 18:1183-1187
74. Martinez J, Sanchez-Paya J, Palazon JM, Suazo-Barahona J, Robles-Diaz G, Perez-Mateo M (2004) Is obesity a risk factor in acute pancreatitis? A meta-analysis. Pancreatology 4:42-48
75. Smits MM, van Geenen EJ (2011) The clinical significance of pancreatic steatosis. Nat Rev Gastroenterol Hepatol 8:169-177
76. Ramsey AM, Martin RC (2011) Body mass index and outcomes from pancreatic resection: a review and meta-analysis. J Gastrointest Surg 15(9):1633-1642
77. Calle EE, Thun MJ, Petrelli JM, Rodriguez C, Heath CW Jr (1999) Body-mass index and mortality in a prospective cohort of U.S. adults. N Engl J Med 341:1097-1105
78. McGee DL (2005) Body mass index and mortality: a meta-analysis based on person-level data from twenty-six observational studies. Ann Epidemiol 15:87-97
79. Calle EE, Rodriquez C, Walker-Thurmond K, Thun MJ (2003) Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 348:1625-1638
80. Prizment AE, Flood A, Anderson KE, Folsom AR (2010) Survival of women with colon cancer in relation to precancer anthropometric characteristics: the Iowa Women's Health Study. Cancer Epidemiol Biomarkers Prev 19:2229-2237
81. Meyerhardt JA, Catalano PJ, Haller DG, Mayer RJ, Benson AB III, Macdonald JS, Fuchs CS (2003) Influence of body mass index on outcomes and treatment-related toxicity in patients with colon carcinoma. Cancer 98:484-495
82. Meyerhardt JA, Niedzwiecki D, Hollis D, Saltz LB, Mayer RJ, Nelson H, Whittom R, Hantel A, Thomas J, Fuchs CS (2008) Impact of body mass index and weight change after treatment on cancer recurrence and survival in patients with stage III colon cancer: findings from Cancer and Leukemia Group B 89803. J Clin Oncol 26:4109-4115
83. McWilliams RR, Matsumoto ME, Burch PA, Kim GP, Halfdanarson TR, de AM, Reid- Lombardo K, Bamlet WR (2010) Obesity adversely affects survival in pancreatic cancer patients. Cancer 116:5054-5062
84. Li D, Morris JS, Liu J, Hassan MM, Day RS, Bondy ML, Abbruzzese JL (2009) Body mass index and risk, age of onset, and survival in patients with pancreatic cancer. JAMA 301:2553-2562
85. Kulig J, Sierzega M, Kolodziejczyk P, Dadan J, Drews M, Fraczek M, Jeziorski A, Krawczyk M, Starzynska T, Wallner G (2010) Implications of overweight in gastric cancer: A multicenter study in a Western patient population. Eur J Surg Oncol 36:969-976
86. Madani K, Zhao R, Lim HJ, Casson SM, Casson AG (2010) Obesity is not associated with adverse outcome following surgical resection of oesophageal adenocarcinoma. Eur J Cardiothorac Surg 38:604-608
87. Melis M, Weber JM, McLoughlin JM, Siegel EM, Hoffe S, Shridhar R, Turaga KK, Dittrick G, Dean EM, Karl RC, Meredith KL (2011) An elevated body mass index does not reduce survival after esophagectomy for cancer. Ann Surg Oncol 18:824-831
88. Aleksandrova K, Boeing H, Jenab M, Bueno-de-Mesquita HB, Jansen E, van Duijnhoven FJ, Fedirko V, Rinaldi S, Romieu I, Riboli E, Romaguera D, Overvad KK, Ostergaard JN, Olsen A, Tjonneland AA, Boutron-Ruault MC, Clavel-Chapelon F, Morois S, Masala G, Agnoli C, Panico S, Tumino R, Vineis P, Kaaks R, Lukanova A, Trichopoulou A, Naska A, Bamia C, Peeters PH, Rodriguez L, Buckland G, Sanchez MJ, Dorronsoro M, Huerta JM, Barricarte GA, Hallmans G, Palmqvist R, Khaw KT, Wareham NJ, Allen NE, Tsilidis KK, Pischon T (2011) Metabolic syndrome and risks of colon and rectal cancer: the European Prospective Investigation into Cancer and Nutrition Study. Cancer Prev Res (Phila) 4(11):1873-1883
89. Stocks T, Lukanova A, Bjorge T, Ulmer H, Manjer J, Almquist M, Concin H, Engeland A, Hallmans G, Nagel G, Tretli S, Veierod MB, Jonsson H, Stattin P (2010) Metabolic factors and the risk of colorectal cancer in 580, 000 men and women in the metabolic syndrome and cancer project (Me-Can). Cancer 2010 Dec 17
90. Rosato V, Tavani A, Bosetti C, Pelucchi C, Talamini R, Polesel J, Serraino D, Negri E, La VC (2011) Metabolic syndrome and pancreatic cancer risk: a case-control study in Italy and metaanalysis. Metabolism 60(10):1372-1378
91. Johansen D, Stocks T, Jonsson H, Lindkvist B, Bjorge T, Concin H, Almquist M, Haggstrom C, Engeland A, Ulmer H, Hallmans G, Selmer R, Nagel G, Tretli S, Stattin P, Manjer J (2010) Metabolic factors and the risk of pancreatic cancer: a prospective analysis of almost 580, 000 men and women in the Metabolic Syndrome and Cancer Project. Cancer Epidemiol Biomarkers Prev 19:2307-2317
92. Ryan AM, Duong M, Healy L, Ryan SA, Parekh N, Reynolds JV, Power DG (2011) Obesity, metabolic syndrome and esophageal adenocarcinoma: epidemiology, etiology and new targets. Cancer Epidemiol 35:309-319
93. Healy LA, Ryan AM, Carroll P, Ennis D, Crowley V, Boyle T, Kennedy MJ, Connolly E, Reynolds JV (2010) Metabolic syndrome, central obesity and insulin resistance are associated with adverse pathological features in postmenopausal breast cancer. Clin Oncol (R Coll Radiol) 22:281-288
94. Welzel TM, Graubard BI, Zeuzem S, El-Serag HB, Davila JA, McGlynn KA (2011) Metabolic syndrome increases the risk of primary liver cancer in the United States: a study in the SEER- medicare database. Hepatology 54:463-471
95. Borena W, Strohmaier S, Lukanova A, Bjorge T, Lindkvist B, Hallmans G, Edlinger M, Stocks T, Nagel G, Manjer J, Engeland A, Selmer R, Haggstrom C, Tretli S, Concin H, Jonsson H, Stattin P, Ulmer H (2011) Metabolic risk factors and primary liver cancer in a prospective study of 578, 700 adults. Int J Cancer 2011 Jul 29. doi: 10.1002/ijc.26338
96. Nock NL, Berger NA (2010) Obesity and cancer: overview of mechanisms. In: Berger NA (ed) Cancer and energy balance, epidemiology and overview. Springer, New York, NY, pp 129-179